IRONWOOD PHARMACEUTICALS INC
For the period ended Dec 31, 2023. Filed Feb 16, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 16, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Signatures
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Boston, Commonwealth of Massachusetts, on the 16 th day of February 2024.
| | ||
|---|---|---|
| | Ironwood Pharmaceuticals, Inc. | |
| | By: | /s/ Thomas Mccourt |
| | | Thomas McCourt |
| | | Chief Executive Officer |
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the date indicated.
| Signature | Title | Date | ||
|---|---|---|---|---|
| | | | | |
| /s/ Thomas McCourt | | Chief Executive Officer and Director (Principal Executive Officer) | | February 16, 2024 |
| Thomas McCourt | | | ||
| | | | | |
| /s/ Sravan k. Emany | | Senior Vice President, Chief Financial Officer (Principal Financial Officer) | | February 16, 2024 |
| Sravan K. Emany | | | ||
| | | | | |
| /s/ Ronald Silver | | Vice President, Corporate Controller (Principal Accounting Officer) | | February 16, 2024 |
| Ronald Silver | | | ||
| | | | | |
| /s/ Julie H. McHugh | | Chair of the Board | | February 16, 2024 |
| Julie H. McHugh | | | ||
| | | | | |
| /s/ Mark Currie | | Director | | February 16, 2024 |
| Mark Currie | | | ||
| | | | | |
| | | Director | | |
| Alexander Denner | | | ||
| | | | | |
| /s/ Andrew Dreyfus | | Director | | February 16, 2024 |
| Andrew Dreyfus | | | ||
| | | | | |
| /s/ Jon Duane | | Director | | February 16, 2024 |
| Jon Duane | | | ||
| | | | | |
| /s/ Marla Kessler | | Director | | February 16, 2024 |
| Marla Kessler | | | ||
| | | | | |
| /s/ Catherine Moukheibir | | Director | | February 16, 2024 |
| Catherine Moukheibir | | | ||
| | | | | |
| /s/ Jay P. Shepard | | Director | | February 16, 2024 |
| Jay P. Shepard | | | ||
| | | | | |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.